Biomarkers of Neurodegenerative Disorders: Current Progress and Future Directions

— —

Rawan Tarawneh

Biomarkers of Neurodegenerative Disorders

Current Progress and Future Directions

Rawan Tarawneh

$621.95 $497.26

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Springer International Publishing AG
02 July 2025

Medical diagnosis; Neurology & clinical neurophysiology; Neurosciences

This book presents state-of-the-art knowledge regarding fluid and imaging biomarkers of neurodegenerative disorders, including Alzheimer disease and related dementias (ADRD). A cadre of the top experts in the field discuss the diagnostic and prognostic value of established and emerging biomarkers in ADRD, their ability to track or monitor disease progression or predict cognitive outcomes, and their potential as novel therapeutic targets. Biomarkers are discussed both in the context of specific disease mechanisms, including amyloid, tau, and synuclein pathologies, endothelial, vascular, neuronal, and synaptic injury, and glial reactivity as well as a wide spectrum of neurodegenerative disorders that encompass various pathologies. Multi-omics approaches in ADRD biomarker and drug target discovery including proteomics, genomics, and transcriptomics are covered. Importantly, the authors highlight the need to integrate biomarkers into various stages of ADRD drug development to accelerate drug discovery and approval. The book provides in-depth insight regarding significant progress in ADRD biomarker research over the last decade, addresses potential challenges in the translation of ADRD biomarkers into the clinic, and proposes important directions for future research.

Edited by: Rawan Tarawneh
Imprint: Springer International Publishing AG
Country of Publication: Switzerland
Dimensions: Height: 235mm, Width: 155mm,
ISBN: 9783031808487
ISBN 10: 3031808487
Pages: 637
Publication Date: 02 July 2025
Audience: Professional and scholarly , College/higher education , Undergraduate , Further / Higher Education
Format: Hardback
Publisher's Status: Active

Rawan Tarawneh, MD is Associate Professor of Neurology and Director of the Cognitive Neurology Division at the University of New Mexico. She is a board-certified neurologist with UCNS- certification in Behavioral Neurology and Neuropsychiatry. Dr Tarawneh completed her neurology residency and a combined clinical and post-doctoral research fellowship at the Knight-Washington University in St Louis Alzheimer Disease Research Center. Her NIH-funded research utilizes state-of-the-art proteomic and genomic methods to identify novel biomarkers and drug targets for Alzheimer disease and related dementias. Dr Tarawneh’s pioneering work has been fundamental in identifying visinin-like protein-1, neurogranin, and vascular endothelial-cadherin as novel markers of neuronal, synaptic, and endothelial injury, respectively, in AD. As a national leader in ADRD biomarker research, Dr Tarawneh has led several clinical trials in aging and dementia. Her highly cited research in ADRD biomarkers has been published in prestigious journals and featured in national and international conferences.